# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-26-023923
Filing Date
2026-04-06
Accepted
2026-04-06 16:30:28
Documents
88
Period of Report
2026-05-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | alny-20260406.htm iXBRL | DEF 14A | 2026478
3 | GRAPHIC | alny-20260406_g1.jpg | GRAPHIC | 33708
4 | GRAPHIC | alny-20260406_g10.jpg | GRAPHIC | 301089
5 | GRAPHIC | alny-20260406_g11.jpg | GRAPHIC | 14994
6 | GRAPHIC | alny-20260406_g12.jpg | GRAPHIC | 479231
7 | GRAPHIC | alny-20260406_g13.jpg | GRAPHIC | 34831
8 | GRAPHIC | alny-20260406_g14.jpg | GRAPHIC | 35385
9 | GRAPHIC | alny-20260406_g15.jpg | GRAPHIC | 35319
10 | GRAPHIC | alny-20260406_g16.jpg | GRAPHIC | 21067
11 | GRAPHIC | alny-20260406_g17.jpg | GRAPHIC | 19276
12 | GRAPHIC | alny-20260406_g18.jpg | GRAPHIC | 36244
13 | GRAPHIC | alny-20260406_g19.jpg | GRAPHIC | 17311
14 | GRAPHIC | alny-20260406_g2.jpg | GRAPHIC | 751615
15 | GRAPHIC | alny-20260406_g20.jpg | GRAPHIC | 35704
16 | GRAPHIC | alny-20260406_g21.jpg | GRAPHIC | 32493
17 | GRAPHIC | alny-20260406_g22.jpg | GRAPHIC | 31897
18 | GRAPHIC | alny-20260406_g23.jpg | GRAPHIC | 37496
19 | GRAPHIC | alny-20260406_g24.jpg | GRAPHIC | 35149
20 | GRAPHIC | alny-20260406_g25.jpg | GRAPHIC | 27453
21 | GRAPHIC | alny-20260406_g26.jpg | GRAPHIC | 35377
22 | GRAPHIC | alny-20260406_g27.jpg | GRAPHIC | 28030
23 | GRAPHIC | alny-20260406_g28.jpg | GRAPHIC | 18591
24 | GRAPHIC | alny-20260406_g29.jpg | GRAPHIC | 33415
25 | GRAPHIC | alny-20260406_g3.jpg | GRAPHIC | 22160
26 | GRAPHIC | alny-20260406_g30.jpg | GRAPHIC | 33415
27 | GRAPHIC | alny-20260406_g31.jpg | GRAPHIC | 19841
28 | GRAPHIC | alny-20260406_g32.jpg | GRAPHIC | 33415
29 | GRAPHIC | alny-20260406_g33.jpg | GRAPHIC | 18062
30 | GRAPHIC | alny-20260406_g34.jpg | GRAPHIC | 16704
31 | GRAPHIC | alny-20260406_g35.jpg | GRAPHIC | 24277
32 | GRAPHIC | alny-20260406_g36.jpg | GRAPHIC | 1121802
33 | GRAPHIC | alny-20260406_g37.jpg | GRAPHIC | 357984
34 | GRAPHIC | alny-20260406_g38.jpg | GRAPHIC | 376622
35 | GRAPHIC | alny-20260406_g39.jpg | GRAPHIC | 368537
36 | GRAPHIC | alny-20260406_g4.jpg | GRAPHIC | 9623
37 | GRAPHIC | alny-20260406_g40.jpg | GRAPHIC | 377962
38 | GRAPHIC | alny-20260406_g41.jpg | GRAPHIC | 319870
39 | GRAPHIC | alny-20260406_g42.jpg | GRAPHIC | 349119
40 | GRAPHIC | alny-20260406_g43.jpg | GRAPHIC | 373896
41 | GRAPHIC | alny-20260406_g44.jpg | GRAPHIC | 423010
42 | GRAPHIC | alny-20260406_g45.jpg | GRAPHIC | 479167
43 | GRAPHIC | alny-20260406_g46.jpg | GRAPHIC | 42968
44 | GRAPHIC | alny-20260406_g47.jpg | GRAPHIC | 21842
45 | GRAPHIC | alny-20260406_g48.jpg | GRAPHIC | 29934
46 | GRAPHIC | alny-20260406_g49.jpg | GRAPHIC | 42448
47 | GRAPHIC | alny-20260406_g5.jpg | GRAPHIC | 461614
48 | GRAPHIC | alny-20260406_g50.jpg | GRAPHIC | 42298
49 | GRAPHIC | alny-20260406_g51.jpg | GRAPHIC | 14994
50 | GRAPHIC | alny-20260406_g52.jpg | GRAPHIC | 44175
51 | GRAPHIC | alny-20260406_g53.jpg | GRAPHIC | 245303
52 | GRAPHIC | alny-20260406_g54.jpg | GRAPHIC | 250971
53 | GRAPHIC | alny-20260406_g55.jpg | GRAPHIC | 241636
54 | GRAPHIC | alny-20260406_g56.jpg | GRAPHIC | 2391771
55 | GRAPHIC | alny-20260406_g57.jpg | GRAPHIC | 245031
56 | GRAPHIC | alny-20260406_g58.jpg | GRAPHIC | 39489
57 | GRAPHIC | alny-20260406_g59.jpg | GRAPHIC | 35500
58 | GRAPHIC | alny-20260406_g6.jpg | GRAPHIC | 25477
59 | GRAPHIC | alny-20260406_g60.jpg | GRAPHIC | 34882
60 | GRAPHIC | alny-20260406_g61.jpg | GRAPHIC | 35733
61 | GRAPHIC | alny-20260406_g62.jpg | GRAPHIC | 35197
62 | GRAPHIC | alny-20260406_g63.jpg | GRAPHIC | 21162
63 | GRAPHIC | alny-20260406_g64.jpg | GRAPHIC | 16260
64 | GRAPHIC | alny-20260406_g65.jpg | GRAPHIC | 33414
65 | GRAPHIC | alny-20260406_g66.jpg | GRAPHIC | 33414
66 | GRAPHIC | alny-20260406_g67.jpg | GRAPHIC | 16379
67 | GRAPHIC | alny-20260406_g68.jpg | GRAPHIC | 15637
68 | GRAPHIC | alny-20260406_g69.jpg | GRAPHIC | 18516
69 | GRAPHIC | alny-20260406_g7.jpg | GRAPHIC | 36143
70 | GRAPHIC | alny-20260406_g70.jpg | GRAPHIC | 19256
71 | GRAPHIC | alny-20260406_g71.jpg | GRAPHIC | 100426
72 | GRAPHIC | alny-20260406_g72.jpg | GRAPHIC | 17223
73 | GRAPHIC | alny-20260406_g73.jpg | GRAPHIC | 145685
74 | GRAPHIC | alny-20260406_g74.jpg | GRAPHIC | 18915
75 | GRAPHIC | alny-20260406_g75.jpg | GRAPHIC | 124715
76 | GRAPHIC | alny-20260406_g76.jpg | GRAPHIC | 229885
77 | GRAPHIC | alny-20260406_g8.jpg | GRAPHIC | 39233
78 | GRAPHIC | alny-20260406_g9.jpg | GRAPHIC | 37020
| Complete submission text file | 0001628280-26-023923.txt |  | 33822931

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | alny-20260406.xsd | EX-101.SCH | 922
91 | EXTRACTED XBRL INSTANCE DOCUMENT | alny-20260406_htm.xml | XML | 132642

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36407 | Film No.: 26841639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)